Teleflex (Teleflex) Total Inventories

: $626 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

Teleflex's total inventories for the quarter that ended in Dec. 2023 was $626 Mil. Teleflex's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $626 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Teleflex's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-47.26.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Teleflex's Days Inventory for the three months ended in Dec. 2023 was 166.69.

Inventory Turnover measures how fast the company turns over its inventory within a year. Teleflex's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.55.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Teleflex's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.81.

Teleflex Total Inventories Historical Data

The historical data trend for Teleflex's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teleflex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

476.56

513.20

477.64

578.51

626.22

Teleflex Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories	Get a 7-Day Free Trial															578.51	614.11	631.56	625.08	626.22

Teleflex Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Teleflex (NYSE:TFX) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Teleflex's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(222.848	+	0.75 * 443.467	+	0.5 * 626.216	-	3091.558
-	0	-	0)	/	47.04
=	-47.26

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Teleflex's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	625.6455	/	342.492	*	365 / 4
	=	166.69

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Teleflex's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	342.492	/	625.6455
	=	0.55

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Teleflex's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	625.6455	/	773.909
	=	0.81

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Teleflex Total Inventories Related Terms

Thank you for viewing the detailed overview of Teleflex's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Teleflex (Teleflex) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Teleflex Inc (NYSE:TFX) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

T1FX34:Brazil

Address

550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087

Website

https://www.teleflex.com

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2022 sales), interventional (16%), anesthesia (14%), surgical (14%), interventional urology (12%), original-equipment manufacturing (10%), and all other (10%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Executives

Liam Kelly	officer: EVP & President, International	IDA BUSINESS AND TECHNOLOGY PARK, DUBLIN ROAD, ATHLONE L2 00000
Thomas E Powell	officer: Senior Vice President & CFO	C/O TOMOTHERAPY INCORPORATED, 1240 DEMING WAY, MADISON WI 53717
Stuart A Randle	director	585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Jaewon Ryu	director	950 N. GLEBE ROAD, SUITE 700, ARLINGTON VA 22203
Neena M Patil	director	JAZZ PHARMACEUTICALS, 3170 PORTER DRIVE, PALO ALTO CA 94304
Andrew A Krakauer	director	CANTEL MEDICAL CORP., 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Cameron P Hicks	officer: Vice President, Global HR	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Klasko Stephen K. M.d.	director	155 SOUTH LIMERICK ROAD, LIMERICK PA 19468
Jay White	officer: VP & Pres, Global Commercial	3015 CARRINGTON MILL BLVD., MORRISVILLE NC 27560
Daniel V. Logue	officer: VP, Gen Counsel & Secretary	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
John Deren	officer: VP & Chief Accounting Officer	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
James J Leyden	officer: VP, General Counsel, Secretary	C/O INFRASOURCE SERVICES, INC, 500 WEST DUTTON MILL ROAD, ASTON PA 19014
James Winters	officer: Vice President, Mfg and Supply	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Mario Wijker	officer: Vice President, QARA	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Benson Smith	director	C/O ROCHESTER MEDICAL INC, ONE ROCHESTER MEDICAL DDRIVE, STEWARTVILLE MN 55976